Italia Markets close in 1 hr 11 mins

Pfizer Inc. (PFE)

NYSE - Nasdaq Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
27,90+0,08 (+0,29%)
In data: 10:19AM EDT. Mercato aperto.

Pfizer Inc.

66 Hudson Boulevard East
New York, NY 10001-2192
United States
212 733 2323
https://www.pfizer.com

Settore/iHealthcare
SettoreDrug Manufacturers—General
Impiegati a tempo pieno88.000

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Dr. Albert Bourla D.V.M., Ph.D.Chairman of the Board & CEO4,05MN/D1962
Mr. David M. DentonChief Financial Officer & Executive VP1,75MN/D1965
Dr. Mikael Dolsten M.D., Ph.D.Chief Scientific Officer and President of Research & Development2,41MN/D1958
Mr. Douglas M. LanklerExecutive VP & General Counsel1,76MN/D1966
Mr. Aamir MalikExecutive VP & Chief U.S. Commercial Officer1,89MN/D1976
Ms. Jennifer B. DamicoSenior VP, Controller & Principal Accounting OfficerN/DN/D1968
Ms. Lidia L. FonsecaExecutive VP and Chief Digital & Technology OfficerN/DN/D1969
Ms. Francesca M. DeMartinoChief Investor Relations OfficerN/DN/DN/D
Mr. Rady A. JohnsonExecutive VP and Chief Compliance, Quality & Risk OfficerN/DN/D1962
Mr. Andreas J. PanayiotouGlobal Chief Marketing OfficerN/DN/DN/D
Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Governance aziendale

L'ISS Governance QualityScore di Pfizer Inc. al 29 maggio 2024 è 5. I criteri di valutazione fondamentali sono revisione: 10; Consiglio di Amministrazione: 5; diritti degli azionisti: 1; retribuzione: 3.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.